NIPH
TXG icon

NN Investment Partners Holdings’s 10x Genomics TXG Stock Holding History

NN Investment Partners Holdings’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.67M Buy
21,880
+1,075
+5% +$94K 0.01% 563
2021
Q4 		$3.1M Buy
20,805
+6,338
+44% +$971K 0.02% 495
2021
Q3 		$2.11M Buy
+14,467
New +$2.48M 0.01% 547

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NN Investment Partners Holdings's TXG Position: Q1 2022 in Review

NN Investment Partners Holdings increased its 10x Genomics (TXG) stake by 5.2% in Q1 2022, buying an estimated $94K and bringing the position to 21,880 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #563.

NN Investment Partners Holdings first reported a position in TXG in Q3 2021 and has held it in 3 quarters since. The position peaked at $3.1M in Q4 2021. 314 funds tracked by Wall St. Rank hold TXG as of Q1 2022.

  • NN Investment Partners Holdings held 21,880 shares of 10x Genomics worth $1.67M as of Q1 2022.
  • NN Investment Partners Holdings bought 1,075 10x Genomics shares in Q1 2022, an estimated $94K.
  • 10x Genomics made up 0.01% of NN Investment Partners Holdings's portfolio in Q1 2022, its #563 holding.
  • NN Investment Partners Holdings first reported a position in 10x Genomics in Q3 2021 and has held it in 3 quarters since.
  • NN Investment Partners Holdings's 10x Genomics position peaked at $3.1M in Q4 2021.
  • 314 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.